Peptide Research in Australia: TGA Rules and Quality Documentation
An evidence-based overview of Australia’s TGA requirements, research-use claims, laboratory COAs, importation considerations and peptide research documentation.
-
-
Peptide Purity vs Sterility: What Laboratory Tests Actually Show
Understand why HPLC purity, molecular identity, sterility and bacterial endotoxins are different laboratory-quality measurements, and what each result can—and cannot—show.
-
Colivelin Peptide: Humanin, STAT3 Signaling and Neuroprotection Research
A research-focused guide to Colivelin peptide, including Humanin-derived signaling, JAK2/STAT3 pathways, neuroprotection models, amyloid-related research and evidence limitations.
-
FGL Peptide: NCAM, FGFR1 Signaling and Neuroplasticity Research
A research-focused guide to FGL peptide, including NCAM-derived FGFR1 signaling, synaptogenesis, neuroplasticity, cognition studies, limited human Phase I data and research limitations.
-
B7-33 Peptide: RXFP1 Signaling, Relaxin Biology and Fibrosis Research
A research-focused guide to B7-33 peptide, including RXFP1 signaling, relaxin biology, anti-fibrotic preclinical studies, evidence limitations and analytical considerations.
-
Larazotide Peptide: Tight Junctions, Zonulin and Celiac Disease Research
A research-focused guide to larazotide peptide, including intestinal tight junctions, zonulin-related permeability, celiac disease trials, evidence limitations and analytical considerations.
-
Dihexa Peptide: HGF/c-Met Signaling, Synaptogenesis and Research Evidence
A research-focused guide to Dihexa peptide, including HGF/c-Met signaling, synaptogenesis, preclinical cognition research, evidence limitations and analytical considerations.
-
Retatrutide vs Semaglutide: Receptor Targets, Structure and Research Differences
Retatrutide and semaglutide are both peptide-based compounds studied in metabolic research, but they are not simply stronger and weaker versions of the same molecule. Their most important difference is receptor pharmacology: semaglutide is designed primarily as a GLP-1 receptor agonist, whereas retatrutide is a triple agonist that engages GLP-1, GIP and glucagon receptors. This guide…
-
Synthetic Peptides vs Recombinant Peptides: What’s the Difference?
Peptides can be produced in more than one way. Two of the most important routes are chemical synthesis and recombinant expression. Both can produce well-defined peptide material, but they use very different manufacturing systems and create different technical advantages, limitations and impurity profiles. This guide explains how synthetic and recombinant peptides differ, why one method…
-
How Peptide Synthesis and Purification Work
A practical overview of how synthetic peptides are assembled, cleaved, purified and analytically checked, including solid-phase peptide synthesis, RP-HPLC and mass spectrometry.
